While the spotlight chases humanoid walking gaits, Linkerbot is answering a more urgent industry question: How do robots ...

Schroders has issued updated long-term forecasts highlighting where it believes the best return prospects sit over the next ...

A newly published manuscript authored by Dr. Gunda Georg, YourChoice Therapeutics and Columbia University Medical Center ...

Crowds flooded the freshly opened showroom floors on day two of CES 2026 and were met by thousands of robots, AI companions, ...

OS Therapies Inc. (NYSE American: OSTX) (“OS Therapies” or the “Company”), the world leader in listeria-based cancer ...

Note Futures, UK Gilt Futures, Euro Bund Futures, Japan Government Bond Futures. Read 's Market Analysis on Investing.com ...

Crowds flooded freshly opened showroom floors on Day 2 of CES, met by thousands of robots, AI companions, assistants, health ...

Multi-target license agreement grants Sidewinder access to Lonza's clinically validated ADC platform -- Sidewinder's pipeline of precision bispecific ADCs combined with Lonza's clinically validated ...

With Lainya, Shearer has a 25-year-old son, Will, and two daughters, Chloe, 32 and Hollie, 30. All three of his offspring ...

Remegen Ltd. has synthesized antibody-drug conjugates consisting of anti-CDCP1 antibodies covalently linked to cytotoxic drugs through linkers reported to be useful for the treatment of cancer.

Haisco Pharmaceutical Group Co. Ltd. has disclosed antibody-drug conjugates consisting of antibodies covalently linked to antitumor drugs through a linker reported to be useful for the treatment of ...